ReNeuron, a life sciences firm currently based in Guildford, UK, is set to relocate to Cardiff’s tech cluster after a £13.8m ($21.2m) investment from the £100m Wales Life Sciences Fund (WLSF).

The funding is part of a wider financing package of £33m backed by a consortium of investors including venture firms Invesco and Abingworth. Aside from the relocation, the funds will be used to begin Phase II trials into ReNeuron’s stem cell technology.

As part of the deal, Sir Chris…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?